仁和品牌怎么样 申请店铺

我要投票 仁和在中草药行业中的票数:1138 更新时间:2026-02-08
仁和是哪个国家的品牌?「仁和」是仁和(集团)发展有限公司旗下著名品牌。该品牌发源于江西,由创始人杨文龙在2001期间创立,经过多年的不懈努力和高速发展,现已成为行业的标杆品牌。

外推网助力仁和品牌出海!将品牌入驻外推网,定制仁和品牌推广信息,可以显著提高仁和产品曝光,简直是跨境电商爆单神器!目前仅需1000元/年哦~

仁和怎么样

仁和(集团)发展有限公司组建于2001年,在党和各级政府的亲切关怀及社会各界的热心帮助下,通过全体员工的艰苦奋斗,现已发展成为一家集药品、保健品生产销售于一体的现代医药企业集团。目前,仁和集团旗下拥有“仁和药业股份有限公司”(证券代码:000650)等多家子公司,员工5000余人。

自创业以来,仁和集团在销售收入、贡献税收等主要经济指标方面,实现了连续6年翻番增长,10年增长66倍的骄人业绩。

仁和工业企业拥有占地总面积40余万平方米的现代化生产基地,注册生产中西药品、保健品等200多个品种,已有胶囊剂、软胶囊剂、滴丸剂、滴眼剂、颗粒剂、片剂、洗剂、橡胶膏剂等29个药品剂型和8个保健食品剂型获得国家GMP认证证书,形成了药品、保健品两大类产品生产板块。

凭籍雄厚的科研实力,仁和集团先后研制、开发了200多个医药、保健产品。仁和集团的“中药集成创新技术平台”项目获得国家资金支持,集团公司被评定为“省级企业技术中心”,所属药都仁和制药、闪亮制药两家公司被双双认定为国家级高新技术企业。目前,仁和集团拥有一支以博士、硕士为主体的技术研发核心团队,并与中国中医药科学院等多家科研院所建立了战略合作关系。仁和集团独立研发的“仁和健心胶囊”产品被列为国家“863”高科技项目,填补了江西省医药“863”高科技项目的空白。

通过成功的市场运作,仁和集团建立了品牌打造的核心竞争力,现已形成由仁和企业品牌和5个主导产品品牌组成的品牌集群。其中,由仁和集团独立研发并享有知识产权的“妇炎洁”系列产品,已经成为中国女性保健护卫市场的领袖品牌产品。仁和牌“优卡丹”、“仁和可立克”、“清火胶囊”,闪亮牌“萘敏维滴眼液”、“复方门冬维甘滴眼液”等产品也都是国内同类产品中的名牌产品。

继“仁和”商标于2007年9月被国家工商总局认定为“中国驰名商标”后,2008年4月,“闪亮”商标经司法认定为“中国驰名商标”。2009年6月,“妇炎洁”第5类商标获得国家商标管理局批准注册。

优质的产品和遍布全国30个省、市、自治区的营销网络,是仁和商业凸显市场竞争力的坚实基础。先进的市场营销和营销管理模式、大规模的广告支持、周到的售后服务、快速有力的物流保障,构成了仁和商业“争天时,取地利,倡人和”的经营特色。

饮水思源,回报社会,是仁和企业与全体员工的共同信念。2006年7月,仁和集团全资赞助了中国第一所“希望医院”——“仁和希望医院”。2008年冻雪灾害期间,仁和集团派出专业工作队奔赴重灾区抢修电力设施。四川省汶川地区遭受特大地震灾害后,仁和集团在江西省率先发起赈灾捐助,企业与员工共计捐助现金和物资近700万元。2009年,仁和集团为昌樟高速公路暨赣江“双桥”建设工程捐资888万元,向江西省“青苗关爱工程”、“仁和博爱送万家”等公益事业和新农村建设等捐款共计300余万元。

自组建以来,仁和集团向“希望工程”、“希望医院”、抢险救灾、修桥筑路及社会弱势群体捐款、捐物累计价值逾4000万元,安置下岗职工和农村剩余劳动力就业近5000人次,受到党和政府及社会各界的充分肯定与高度赞扬,获得多项荣誉称号。

Renhe (Group) Development Co., Ltd. was established in 2001. With the cordial care of the party and governments at all levels and the enthusiastic help of all sectors of society, through the hard work of all employees, it has developed into a modern pharmaceutical enterprise group integrating the production and sales of drugs and health care products. At present, Renhe group has many subsidiaries including "Renhe Pharmaceutical Co., Ltd" (securities code: 000650), with more than 5000 employees. Since its establishment, Renhe group has achieved six consecutive years of double growth in terms of sales revenue, contribution tax and other major economic indicators, and 66 times of growth in 10 years. Renhe Industrial enterprise has a modern production base covering a total area of more than 400000 square meters, registered to produce more than 200 varieties of Chinese and Western medicine and health products, and has 29 pharmaceutical formulations such as capsules, soft capsules, dropping pills, eye drops, granules, tablets, lotions, rubber plasters and 8 health food formulations, which have obtained the national GMP certificate, forming two major pharmaceutical and health products Class a product production section. With strong scientific research strength, Renhe group has developed more than 200 medical and health care products. Renhe group's "integrated innovation technology platform for traditional Chinese medicine" project was supported by national funds. The group company was rated as "provincial enterprise technology center", and its pharmaceutical capital Renhe pharmaceutical and shinning pharmaceutical were both recognized as national high-tech enterprises. At present, Renhe group has a core technology R & D team with doctors and masters as the main body, and has established strategic cooperation with many scientific research institutes such as China Academy of traditional Chinese medicine and pharmacy. Renhe Jianxin capsule, independently developed by Renhe group, is listed as the national "863" high-tech project, which fills the gap in the "863" high-tech project of Jiangxi medicine. Through successful market operation, Renhe group has established the core competitiveness of brand building, and now has formed a brand cluster consisting of Renhe enterprise brand and five leading product brands. Among them, "fuyanjie" series products independently developed by Renhe group and enjoying intellectual property rights have become the leading brand products in China's women's health care market. Renhe brand "ucadan", "Renhe Kerik", "Qinghuo capsule", shinning brand "naphthalene sensitive eye drops", "compound menthol Wigan eye drops" and other products are also famous brand products in domestic similar products. After Renhe trademark was recognized as "China's well-known trademark" by the State Administration of industry and Commerce in September 2007, shinning trademark was recognized as "China's well-known trademark" by judicial authorities in April 2008. In June 2009, "fuyanjie" category 5 trademark was approved for registration by the state trademark administration. The high-quality products and the marketing network covering 30 provinces, cities and autonomous regions are the solid foundation for Renhe business to highlight its market competitiveness. Advanced marketing and marketing management mode, large-scale advertising support, thoughtful after-sales service and fast and powerful logistics guarantee constitute the business characteristics of Renhe business, which is "competing for the time, taking advantage of the place and advocating harmony of people". It is the common belief of Renhe enterprise and all its employees to drink water and think of the source and repay the society. In July 2006, Renhe group wholly sponsored "Renhe Hope Hospital", the first "Hope Hospital" in China. During the snow disaster in 2008, Renhe group sent a professional team to rush to the disaster area to repair the power facilities. After the Wenchuan earthquake in Sichuan Province, Renhe group took the lead in initiating disaster relief donations in Jiangxi Province, with enterprises and employees contributing nearly 7 million yuan in cash and materials. In 2009, Renhe Group donated 8.88 million yuan for the construction of Changzhang Expressway and Ganjiang "double bridge" project, and donated more than 3 million yuan to public welfare undertakings such as "Qingmiao care project", "Renhe fraternity to send thousands of families" and new rural construction in Jiangxi Province. Since its establishment, Renhe group has donated more than 40 million yuan to "Hope Project", "Hope Hospital", rescue and relief work, bridge and road construction, social vulnerable groups, and donated goods. It has resettled laid-off workers and rural surplus labor force for nearly 5000 people. It has been fully affirmed and highly praised by the party, government and all sectors of society, and won many honorary titles.

本文链接: https://brand.waitui.com/a8f386cf6.html 联系电话:请联系客服添加 联系邮箱:请联系客服添加

外推网广告位招租,每天只要9块9

7×24h 快讯

国联民生:拟向民生证券增资2亿元

2月8日,国联民生公告,公司拟向民生证券增资2亿元,增资后公司对民生证券持股比例不变。本次增资的资金来源为公司向特定对象发行股票募集的配套资金,用于民生证券财富管理业务发展和信息技术投入。(第一财经)

2小时前

明冠新材:终止太阳能背板及功能性膜生产基地项目投资协议

2月8日,明冠新材公告,公司决定终止与肥东县人民政府签订的太阳能背板及功能性膜生产基地项目投资合作协议。该项目总投资预计50亿元,目前公司正积极配合肥东县政府办理定制物业的竣工验收等后续工作。自2023年第四季度起,光伏行业已出现产能过剩苗头,产业链产品价格竞争随之加剧,行业处于产业调整周期,2024年和2025年度出现光伏行业普遍亏损。公司管理层在对市场变化认真分析及谨慎研判的基础上,考虑行业内卷导致光伏封装材料盈利能力逐步下降,加之2025年行业竞争白热化且周期性调整尚未呈现明显好转,若继续推进明冠合肥项目,将不可避免地推高公司整体运营成本。(界面新闻)

2小时前

马斯克:是时候大规模重返月球了

2月8日,马斯克发帖表示,是时候大规模重返月球了。此外,有消息称SpaceX正在奥斯汀和西雅图招聘工程师,以开发人工智能卫星和太空数据中心。马斯克转发相关帖子并回复称:是真的。(财联社)

2小时前

杉杉股份:若重整成功,公司实际控制人将变更为安徽省国资委

2月8日,杉杉股份公告称,公司控股股东杉杉集团及其全资子公司宁波朋泽贸易有限公司、杉杉集团管理人与重整投资人安徽皖维集团有限责任公司和宁波金融资产管理股份有限公司签署了《重整投资协议》。若本次重整成功,公司的控制权将发生变更,公司控股股东将变更为皖维集团,公司实际控制人将变更为安徽省国资委。(财联社)

2小时前

国投白银LOF:提示交易价格溢价风险并公布停复牌安排

2月8日,国投白银LOF公告称,近期其二级市场交易价格明显高于基金份额净值,溢价幅度较大。为保护投资者利益,基金将于2026年2月9日开市起至10:30停牌,10:30复牌。若当日溢价幅度未有效回落,基金有权采取进一步措施。自2026年1月28日起,基金已暂停申购(含定期定额投资)业务,恢复时间另行公告。目前基金运作正常,无应披露未披露重大信息。(每日经济新闻)

2小时前

本页详细列出关于仁和的品牌信息,含品牌所属公司介绍,仁和所处行业的品牌地位及优势。
咨询